Press Releases 2015
Subcutaneous defibrillators now recommended by the 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - Aug 31, 2015
Boston Scientific welcomes the updated guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death announced during ...
Boston Scientific announces CE mark for MRI compatible labelling for ICD and CRT-D Systems - August 24, 2015
Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity)...
Boston Scientific EMBLEM™ S-ICD System named most innovative product at EHRA EUROPACE-CARDIOSTIM 2015 - June 23, 2015
Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM™ S-ICD System as the most innovative product...
Boston scientific initiates global study to assess EMBLEM™ subcutaneous implantable defibrillator (S-ICD) in primary prevention patients with low ejection fraction - June 22, 2015
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™ Subcutaneous Implantable ...
Please join us for a Boston Scientific press event. Protection from sudden cardiac death, just under the skin: the EMBLEM™ Subcutaneous ICD System - April 08, 2015
SAVE THE DATE. JUNE 23, 2015. Milan, Italy.
We would like to invite you to our press event on June 23, 2015 dedicated to an innovative, life-saving technology ...
Boston scientific initiates global study to assess EMBLEM™ subcutaneous implantable defibrillator (S-ICD) in primary prevention patients with low ejection fraction - June 22, 2015
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™ Subcutaneous Implantable ...
Please join us for a Boston Scientific press event. Protection from sudden cardiac death, just under the skin: the EMBLEM™ Subcutaneous ICD System - April 08, 2015
SAVE THE DATE. JUNE 23, 2015. Milan, Italy.
We would like to invite you to our press event on June 23, 2015 dedicated to an innovative, life-saving technology ...
Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System - Mar 17, 2015
Boston Scientific Corporation (NYSE: BSX) has received FDA and CE Mark approval of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) System.
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com